BioHarvest Sciences Authorizes 5% Share Repurchase Program

Key Facts

1BioHarvest Sciences' Board of Directors authorized a share repurchase program structured as a normal course issuer bid (NCIB).

2The company believes the current market price of its common shares may not fully reflect the underlying value and future growth prospects.

BioHarvest Sciences' Board of Directors authorized a share repurchase program structured as a normal course issuer bid (NCIB). Newsfile Corp. reported that the company is permitted to purchase up to 5% of its outstanding common shares, equating to a maximum of 1,133,392 shares, with transactions to be executed through Nasdaq facilities.

The company believes the current market price of its common shares may not fully reflect the underlying value and future growth prospects of its business. BHST closed at $1.45 on September 28, 2026, having traded between a day low of $1.44 and a day high of $1.49 during that session.